Related Experiment Videos
Lipocytes and transitional cells in alcoholic liver disease: a morphometric study
1Alcohol Research and Treatment Center, Bronx Veterans Administration Medical Center, New York 10468.
Hepatology (Baltimore, Md.)
|September 1, 1988
Summary
In alcoholic liver disease, a shift from lipocytes to transitional cells occurs as fibrosis progresses. This transformation, observed in liver biopsies, indicates transitional cells may originate from lipocytes.
Area of Science:
- Hepatology
- Cell Biology
- Pathology
Background:
- Alcoholic liver disease (ALD) is a major cause of chronic liver disease.
- Perisinusoidal cells, including lipocytes, play a critical role in liver fibrogenesis.
- Understanding cellular changes in ALD is crucial for developing targeted therapies.
Purpose of the Study:
- To quantitatively analyze lipocytes and transitional cells in liver biopsies from alcoholic patients.
- To investigate the relationship between cellular changes and the progression of hepatic fibrosis in ALD.
- To determine if transitional cells are derived from lipocytes.
Main Methods:
- Quantitative morphometry was performed on liver biopsy specimens from 17 alcoholic patients.
- Cellular populations (lipocytes and transitional cells) were analyzed in different stages of ALD (fatty liver, fatty liver with perivenular fibrosis, cirrhosis).
- Digitized morphometry was used to measure cell surface area.
Main Results:
- In fatty livers, 93% of perisinusoidal cells were lipocytes.
- In cirrhosis, lipocytes decreased to 45%, while transitional cells increased to 55%.
- Transitional cells were significantly smaller than lipocytes and their numbers increased with fibrosis severity, suggesting derivation from lipocytes.
Conclusions:
- Hepatic fibrosis in ALD is associated with a significant shift from lipocytes to transitional cells.
- Transitional cells likely originate from lipocytes, indicating a dynamic cellular response to alcohol-induced liver injury.
- These findings contribute to understanding the cellular mechanisms underlying liver fibrosis in ALD.